Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), announced the launch of Foresight™ Pro 45 cm inner diameter (ID) chromatography columns, designed to support downstream process-scale chromatography applications.

Aptamer Group plc (AIM: APTA), the developer of novel Optimer® binders to enable innovation in the life sciences industry, announces the signing of a new development contract with a rare disease biopharmaceutical company.

LNP developers now have access to bench-to-patient lipid synthesis support from a single partner.

Protheragen-ING Lab, a Good Laboratory Practices (GLP) service provider, has recently unveiled its cutting-edge medical device services.

AMSBIO has implemented a program of investment to support the students at Penn State Lehigh Valley, part of Pennsylvania State University, in their transformative Course-based Undergraduate Research Experience (CURE) program.

Alfa Chemistry now has an extensive range of products within the pharmaceutical field, including PROTAC building blocks, nucleosides, intermediates and Active Pharmaceutical Ingredients (APIs).

Abselion, has secured £6.6 million in Series A financing to bring its award-winning Amperia system to market.

Researchers can conduct large-scale transcriptomics and proteomics data analyses on secure, cloud-based platform to accelerate biomarker discovery and drug repurposing applications.

Aptamer Group plc, the developer of novel Optimer® binders to enable innovation in the life sciences industry, is pleased to announce three new members to its Scientific Advisory Board (SAB).

Refeyn, has developed and launched a custom software platform providing automated analysis of large mass photometry data sets.